Correlation Between Unicycive Therapeutics and Aerovate Therapeutics
Can any of the company-specific risk be diversified away by investing in both Unicycive Therapeutics and Aerovate Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unicycive Therapeutics and Aerovate Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Unicycive Therapeutics and Aerovate Therapeutics, you can compare the effects of market volatilities on Unicycive Therapeutics and Aerovate Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unicycive Therapeutics with a short position of Aerovate Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unicycive Therapeutics and Aerovate Therapeutics.
Diversification Opportunities for Unicycive Therapeutics and Aerovate Therapeutics
0.73 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Unicycive and Aerovate is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding Unicycive Therapeutics and Aerovate Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aerovate Therapeutics and Unicycive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unicycive Therapeutics are associated (or correlated) with Aerovate Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aerovate Therapeutics has no effect on the direction of Unicycive Therapeutics i.e., Unicycive Therapeutics and Aerovate Therapeutics go up and down completely randomly.
Pair Corralation between Unicycive Therapeutics and Aerovate Therapeutics
Given the investment horizon of 90 days Unicycive Therapeutics is expected to generate 2.66 times more return on investment than Aerovate Therapeutics. However, Unicycive Therapeutics is 2.66 times more volatile than Aerovate Therapeutics. It trades about 0.37 of its potential returns per unit of risk. Aerovate Therapeutics is currently generating about -0.02 per unit of risk. If you would invest 53.00 in Unicycive Therapeutics on September 12, 2024 and sell it today you would earn a total of 27.00 from holding Unicycive Therapeutics or generate 50.94% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Unicycive Therapeutics vs. Aerovate Therapeutics
Performance |
| Timeline |
| Unicycive Therapeutics |
| Aerovate Therapeutics |
Unicycive Therapeutics and Aerovate Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Unicycive Therapeutics and Aerovate Therapeutics
The main advantage of trading using opposite Unicycive Therapeutics and Aerovate Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unicycive Therapeutics position performs unexpectedly, Aerovate Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aerovate Therapeutics will offset losses from the drop in Aerovate Therapeutics' long position.| Unicycive Therapeutics vs. Transcode Therapeutics | Unicycive Therapeutics vs. Cardio Diagnostics Holdings |
| Aerovate Therapeutics vs. Adagene | Aerovate Therapeutics vs. Acrivon Therapeutics, Common | Aerovate Therapeutics vs. Rezolute | Aerovate Therapeutics vs. AN2 Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Complementary Tools
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Transaction History View history of all your transactions and understand their impact on performance |